Philips: quarterly loss on heavy provision
On an adjusted basis, the Dutch medical technology group posted an EBITA margin of 9.4% on sales of 4.1 billion euros, up 2.4% on a like-for-like basis thanks to both mature and growth regions.
This growth was achieved despite a decline in China, where the market is impacted by anti-corruption measures and depressed household demand. Because of this country, Philips' order intake fell by 3.8% on a comparable basis.
Philips nevertheless confirms its target of an adjusted EBITA margin of 11-11.5% and like-for-like sales growth of 3-5% for 2024, as well as its confidence in its 2025 plan "while recognizing that uncertainties remain".
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction